Patents 185show all

  • 75
    A61K - Preparations for medical, dental, or toilet purposes
  • 29
    C07D - Heterocyclic compounds
  • 25
    C07K - Peptides
  • 15
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 12
    C08L - Compositions of macromolecular compounds
  • 9
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 7
    C12N - Microorganisms or enzymes
  • 4
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

Clinical Trials 4show all

4Phase 1

SEC Filings show all


29
8-K

8
10-Q

7
D

2
10-K

1
S-1

Contact Information

Cambridge, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2015-03-03$35,450,006$10,128,576Equity
2014-04-08$14,505,371$14,505,371Equity, Option to Acquire, Security to be Acquired
2012-08-09$26,999,708$12,500,164Equity, Option to Acquire, Security to be Acquired
2012-04-18$10,000,000$10,000,000Debt
2010-02-26$3,500,000$2,500,000Debt
2009-02-23Unknown Unknown Other (Paper Filing)

Key Executives

  • Julie A. Olson
    Executive Officer, Director
  • Peter Leone
    Executive Officer
  • Nicholas G. Bacopoulous
    Director
  • C. Clarke Boyd
    Director
  • Joyce Tsang
    Director
  • Martin Vogelbaum
    Director
  • Thomas Beck
    Director
  • Nicholas G. Bacopoulos
    Executive Officer, Director
  • Michael Metzger
    Executive Officer
  • C. Boyd Clarke
    Director
  • Timothy B. Lowinger
    Executive Officer
  • Burkhard Blank
    Executive Officer
  • Sara Nayeem
    Director
  • David Mott
    Director
  • Karen Hong
    Director
  • Eva Jack
    Executive Officer
  • Donald Bergstrom
    Executive Officer
  • Peter Park
    Executive Officer
  • Wayne Foster
    Executive Officer
  • Anna Protopapas
    Executive Officer
  • Timothy Lowinger
    Executive Officer
  • Elaine Jones
    Director